Decreased catalytic function with altered sumoylation of DNA topoisomerase I in the nuclei of scleroderma fibroblasts (Q35617691)

9 August 2017

Decreased catalytic function with altered sumoylation of DNA topoisomerase I in the nuclei of scleroderma fibroblasts (English)

1 reference

9 August 2017

1 reference

Xiaodong Zhou

1

1 reference

9 August 2017

Wei Lin

2

1 reference

9 August 2017

Filemon K Tan

3

1 reference

9 August 2017

Shervin Assassi

4

1 reference

9 August 2017

Mavin J Fritzler

5

1 reference

9 August 2017

Xinjian Guo

6

1 reference

9 August 2017

Roozbeh Sharif

7

1 reference

9 August 2017

Tom Xia

8

1 reference

9 August 2017

Syeling Lai

9

1 reference

9 August 2017

Frank C Arnett

10

1 reference

9 August 2017

9 August 2011

1 reference

Arthritis Research and Therapy

9 August 2017

1 reference

9 August 2017

13

1 reference

9 August 2017

4

1 reference

9 August 2017

R128

1 reference

describes a project that uses

9 August 2017

ImageQuant

object named as

ImageQuant

2 references

11 June 2022

https://www.ebi.ac.uk/europepmc/webservices/rest/PMC3239368/fullTextXML

inferred from PubMed Central ID database lookup

CZ Software Mentions: A large dataset of software mentions in the biomedical literature

exact match

https://scigraph.springernature.com/pub.10.1186/ar3435

0 references

cites work

HLA-DPB1 and DPB2 are genetic loci for systemic sclerosis: a genome-wide association study in Koreans with replication in North Americans

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3239368

Major histocompatibility complex (MHC) class II alleles, haplotypes and epitopes which confer susceptibility or protection in systemic sclerosis: analyses in 1300 Caucasian, African-American and Hispanic cases and 1000 controls

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3239368

Nonclassic functions of human topoisomerase I: genome-wide and pharmacologic analyses

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3239368

Modification of nuclear PML protein by SUMO-1 regulates Fas-induced apoptosis in rheumatoid arthritis synovial fibroblasts

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3239368

Human DNA topoisomerase I: relaxation, roles, and damage control

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3239368

SUMO wrestling with type 1 diabetes

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3239368

Distinct effects of topoisomerase I and RNA polymerase I inhibitors suggest a dual mechanism of nucleolar/nucleoplasmic partitioning of topoisomerase I.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3239368

New insights into the pathogenesis of systemic sclerosis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3239368

Sumoylation of topoisomerase I is involved in its partitioning between nucleoli and nucleoplasm and its clearing from nucleoli in response to camptothecin

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3239368

Cellular roles of dna topoisomerases: a molecular perspective

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3239368

Subnuclear distribution of topoisomerase I is linked to ongoing transcription and p53 status

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3239368

Targeted disruption of the mouse topoisomerase I gene by camptothecin selection

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3239368

DNA topoisomerase I is essential in Drosophila melanogaster

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3239368

Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3239368

Topoisomerase I identified by scleroderma 70 antisera: enrichment of topoisomerase I at the centromere in mouse mitotic cells before anaphase

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3239368

Scl 70 antibody--a specific marker of systemic sclerosis.

12 July 2018

1 reference

Nucleolar delocalization of human topoisomerase I in response to topotecan correlates with sumoylation of the protein

21 January 2018

1 reference

Preliminary criteria for the classification of systemic sclerosis (scleroderma)

21 January 2018

1 reference

Topotecan and the development of scleroderma or a scleroderma-like illness

21 January 2018

1 reference

RNA synthesis inhibitors alter the subnuclear distribution of DNA topoisomerase I

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3239368

Direct binding of anti-DNA topoisomerase I autoantibodies to the cell surface of fibroblasts in patients with systemic sclerosis

15 November 2018

1 reference

12 December 2020

Endothelial and fibroblastic activation in scleroderma: The myth of the “uninvolved skin”

1 reference

12 December 2020

Autoantibodies to fibrillarin in systemic sclerosis (scleroderma). An immunogenetic, serologic, and clinical analysis

1 reference

12 December 2020

Autoantigen components recognizable by scleroderma sera are exported via ectocytosis of fibroblasts

1 reference

12 December 2020

Systemic sclerosis: an autoantibody mosaic

1 reference

12 December 2020

Is anti-topoisomerase I a serum marker of pulmonary involvement in systemic sclerosis?

1 reference

12 December 2020

Recruitment of topoisomerase I (Scl-70) to nucleoplasmic proteasomes in response to xenobiotics suggests a role for altered antigen processing in scleroderma

1 reference

12 December 2020

The many faces of scleroderma

1 reference

12 December 2020

Longitudinal analysis of autoantibody response to topoisomerase I in systemic sclerosis

1 reference

12 December 2020

Identifiers

DOI

10.1186/AR3435

1 reference

Dimensions Publication ID

9 August 2017

0 references

1 reference

9 August 2017

1 reference